YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,GeoLocation,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,54.9,60.8,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,55.7,61.4,Overall,Overall,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,51.9,60.4,Gender,Male,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.4,57.4,,,53.2,61.5,Gender,Male,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,55.6,63.7,Gender,Female,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,55.9,63.7,Gender,Female,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,54.9,60.9,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,55.6,61.5,Race/Ethnicity,"White, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.9,56.9,,,47.4,66,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56,56,,,47.2,64.5,Race/Ethnicity,"Other, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,51,83.5,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AK,Alaska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.5,70.5,,,53.3,83.4,Race/Ethnicity,"Multiracial, non-Hispanic","(64.84507995700051, -147.72205903599973)",02,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.7,64.6,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.9,61.9,,,60,63.8,Overall,Overall,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,57.9,64.3,Gender,Male,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,57.8,64,Gender,Male,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.7,66.3,Gender,Female,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,60.5,65,Gender,Female,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.8,66.1,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.4,64.7,Race/Ethnicity,"White, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,57.6,65.8,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,58.2,66.1,Race/Ethnicity,"Black, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,34.3,34.3,,,21.3,50.3,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,39,39,,,29.1,49.8,Race/Ethnicity,"Other, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.2,52.2,,,34.4,69.5,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AL,Alabama,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.1,50.1,,,34.5,65.7,Race/Ethnicity,"Multiracial, non-Hispanic","(32.84057112200048, -86.63186076199969)",01,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,55.8,61,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.4,59.8,Overall,Overall,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,51.5,59.9,Gender,Male,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.9,54.9,,,50.7,59.1,Gender,Male,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,57.6,64,Gender,Female,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.2,59.2,,,55.9,62.5,Gender,Female,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59,59,,,56.1,61.8,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.2,60,Race/Ethnicity,"White, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,47.8,63.4,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,49.8,64.4,Race/Ethnicity,"Black, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,57.4,84.4,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.2,70.2,,,57.3,80.5,Race/Ethnicity,"Other, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AR,Arkansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.74865012400045, -92.27449074299966)",05,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,59.6,62.9,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,58.3,61.7,Overall,Overall,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.8,59.8,,,57.2,62.4,Gender,Male,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.5,58.5,,,55.8,61.1,Gender,Male,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.5,64.6,Gender,Female,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.4,61.4,,,59.2,63.5,Gender,Female,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.4,64.4,,,62.7,66.1,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.8,64.4,Race/Ethnicity,"White, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,53.1,73.7,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,54,72.3,Race/Ethnicity,"Black, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.2,50.2,,,44.8,55.6,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.5,51.5,,,46.4,56.5,Race/Ethnicity,Hispanic,"(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.3,50.3,,,42.3,58.3,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.3,50.3,,,42.6,58.1,Race/Ethnicity,"Other, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.1,67.1,,,50.1,80.5,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,AZ,Arizona,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,57.1,81.9,Race/Ethnicity,"Multiracial, non-Hispanic","(34.865970280000454, -111.76381127699972)",04,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,58.8,63.3,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,58.4,62.8,Overall,Overall,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,55.8,62.4,Gender,Male,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.6,59.6,,,56.4,62.7,Gender,Male,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.9,62.9,,,59.7,66,Gender,Female,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,58.6,64.9,Gender,Female,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.4,67.4,,,64.8,69.9,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.9,65.9,,,63.4,68.4,Race/Ethnicity,"White, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,64.3,80.2,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.4,72.4,,,64.2,79.4,Race/Ethnicity,"Black, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,44.8,44.8,,,39.9,49.8,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,45,45,,,40.1,50,Race/Ethnicity,Hispanic,"(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.6,57.6,,,48.3,66.4,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.8,55.8,,,47,64.1,Race/Ethnicity,"Other, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,42.4,73,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CA,California,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,46.8,74.9,Race/Ethnicity,"Multiracial, non-Hispanic","(37.63864012300047, -120.99999953799971)",06,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,63.1,66,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,62.6,65.4,Overall,Overall,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.4,64.7,Gender,Male,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,59.7,63.9,Gender,Male,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.4,66.4,,,64.4,68.3,Gender,Female,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66,66,,,64.1,67.9,Gender,Female,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.2,66.2,,,64.7,67.8,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.4,65.4,,,63.9,66.9,Race/Ethnicity,"White, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.7,72.7,,,63.4,80.4,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,60.9,78.3,Race/Ethnicity,"Black, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,47.2,57.7,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.7,53.7,,,48.6,58.6,Race/Ethnicity,Hispanic,"(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.8,64.8,,,53.4,74.7,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.1,68.1,,,58.1,76.6,Race/Ethnicity,"Other, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.7,56.7,,,43.2,69.2,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CO,Colorado,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,44.1,67,Race/Ethnicity,"Multiracial, non-Hispanic","(38.843840757000464, -106.13361092099967)",08,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,69,72.8,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,68.8,72.6,Overall,Overall,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.5,69.5,,,66.6,72.3,Gender,Male,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.4,69.4,,,66.6,72.2,Gender,Male,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.2,72.2,,,69.6,74.7,Gender,Female,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72,72,,,69.3,74.5,Gender,Female,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.7,72.7,,,70.5,74.7,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.2,72.2,,,70.1,74.2,Race/Ethnicity,"White, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,61.6,76.8,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.2,69.2,,,61.2,76.2,Race/Ethnicity,"Black, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,51.6,68.3,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,55,70.7,Race/Ethnicity,Hispanic,"(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.4,59.4,,,44.4,72.8,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.5,58.5,,,45.6,70.2,Race/Ethnicity,"Other, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,CT,Connecticut,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.56266102000046, -72.64984095199964)",09,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,60.6,67.2,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,60.5,67.1,Overall,Overall,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.7,61.7,,,56.1,67,Gender,Male,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.1,62.1,,,56.6,67.4,Gender,Male,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,61.9,69.8,Gender,Female,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.3,65.3,,,61.3,69.1,Gender,Female,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.2,71.2,,,66.6,75.4,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,65.7,74.6,Race/Ethnicity,"White, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.6,58.6,,,53.5,63.5,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,53.8,63.7,Race/Ethnicity,"Black, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,38.4,71.8,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57,57,,,41.6,71.1,Race/Ethnicity,"Other, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,DC,District of Columbia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.907192, -77.036871)",11,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.8,68.8,,,66.2,71.2,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.1,68.1,,,65.6,70.5,Overall,Overall,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,63.1,71.1,Gender,Male,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.5,66.5,,,62.5,70.3,Gender,Male,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.2,70.2,,,67,73.2,Gender,Female,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.6,69.6,,,66.4,72.6,Gender,Female,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.7,70.7,,,68,73.3,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.6,69.6,,,66.8,72.3,Race/Ethnicity,"White, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,56.3,71.1,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.8,64.8,,,57.8,71.2,Race/Ethnicity,"Black, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,40,71.3,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,50.3,73.3,Race/Ethnicity,Hispanic,"(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,53.8,73.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,DE,Delaware,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,52.4,71.5,Race/Ethnicity,"Multiracial, non-Hispanic","(39.008830667000495, -75.57774116799965)",10,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.2,64.2,,,62.3,66,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.5,62.5,,,60.7,64.3,Overall,Overall,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,58.3,64.1,Gender,Male,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,57.1,62.7,Gender,Male,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.8,66.8,,,64.5,69,Gender,Female,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.8,64.8,,,62.6,67.1,Gender,Female,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,65.9,69.8,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,63.1,67,Race/Ethnicity,"White, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,59.5,71.5,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,61.4,72.3,Race/Ethnicity,"Black, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.7,52.7,,,46.7,58.6,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.1,53.1,,,47.6,58.4,Race/Ethnicity,Hispanic,"(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.3,50.3,,,37.5,63,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.6,52.6,,,40.6,64.3,Race/Ethnicity,"Other, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.1,58.1,,,43,71.9,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,FL,Florida,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.5,57.5,,,42.8,71,Race/Ethnicity,"Multiracial, non-Hispanic","(28.932040377000476, -81.92896053899966)",12,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,,,61.7,66.2,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,61.6,66,Overall,Overall,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,,,58.7,65.8,Gender,Male,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,58.8,65.7,Gender,Male,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.4,65.4,,,62.6,68.2,Gender,Female,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.4,67.9,Gender,Female,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,63.4,68.5,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,62.4,67.6,Race/Ethnicity,"White, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66,66,,,61.4,70.4,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,61.5,70.5,Race/Ethnicity,"Black, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,25.9,25.9,,,15.9,39.3,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,32.7,32.7,,,21.4,46.3,Race/Ethnicity,Hispanic,"(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,GA,Georgia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.83968109300048, -83.62758034599966)",13,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,40.7,40.7,,,36.4,45.1,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,41.5,41.5,,,37.1,45.9,Overall,Overall,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.7,43.7,,,37.4,50.2,Gender,Male,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,44.5,44.5,,,38.4,50.9,Gender,Male,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.5,37.5,,,31.8,43.5,Gender,Female,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,38.2,38.2,,,32.5,44.2,Gender,Female,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,44.9,73.8,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,45.2,70.4,Race/Ethnicity,"White, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,49.8,49.8,,,35.6,64,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.2,50.2,,,38.3,62,Race/Ethnicity,Hispanic,"(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37,37,,,31.9,42.4,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,37.1,37.1,,,32,42.5,Race/Ethnicity,"Other, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,38.9,38.9,,,27.7,51.4,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,GU,Guam,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,36.7,36.7,,,26,48.8,Race/Ethnicity,"Multiracial, non-Hispanic","(13.444304, 144.793731)",66,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.1,66.1,,,63.8,68.4,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.8,67.5,Overall,Overall,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,60.7,67.3,Gender,Male,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,60.3,66.8,Gender,Male,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,64.9,71.2,Gender,Female,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.7,66.7,,,63.4,69.9,Gender,Female,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,64.1,71.5,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,63,70.6,Race/Ethnicity,"White, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65,65,,,55.9,73,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,57.6,74,Race/Ethnicity,Hispanic,"(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.5,66.5,,,62.7,70.2,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,61.1,68.8,Race/Ethnicity,"Other, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.7,64.7,,,60.3,68.9,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,HI,Hawaii,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.4,64.4,,,60,68.7,Race/Ethnicity,"Multiracial, non-Hispanic","(21.304850435000446, -157.85774940299973)",15,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,64,67.6,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,63.2,66.8,Overall,Overall,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.8,63.8,,,61,66.5,Gender,Male,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,60.4,65.9,Gender,Male,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.7,67.7,,,65.3,70,Gender,Female,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,64.5,69.2,Gender,Female,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.1,67.1,,,65.3,68.9,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,64.5,68.1,Race/Ethnicity,"White, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.5,47.5,,,31.3,64.3,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.7,48.7,,,34.1,63.6,Race/Ethnicity,"Black, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IA,Iowa,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.46940091300047, -93.81649055599968)",19,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,56.6,61.6,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.7,57.7,,,55.3,60.1,Overall,Overall,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57,57,,,53.1,60.8,Gender,Male,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.5,55.5,,,51.7,59.3,Gender,Male,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,57.8,64.4,Gender,Female,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.7,59.7,,,56.6,62.7,Gender,Female,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,58.3,63.5,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.5,61.6,Race/Ethnicity,"White, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,46.4,46.4,,,32.6,60.9,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.6,48.6,,,36.4,61,Race/Ethnicity,Hispanic,"(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ID,Idaho,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.682630005000476, -114.3637300419997)",16,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.5,60.5,,,57.9,63,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.3,60.3,,,57.8,62.8,Overall,Overall,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,56.1,64.1,Gender,Male,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,55.6,63.4,Gender,Male,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.8,60.8,,,57.5,64,Gender,Female,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.9,60.9,,,57.7,64.1,Gender,Female,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60,65.3,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,59.6,64.9,Race/Ethnicity,"White, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.4,56.4,,,48.1,64.4,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,48.2,63.3,Race/Ethnicity,"Black, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.2,50.2,,,38.8,61.6,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.2,51.2,,,40.2,62.2,Race/Ethnicity,Hispanic,"(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.7,58.7,,,42.3,73.3,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,38.1,66,Race/Ethnicity,"Other, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IL,Illinois,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.48501028300046, -88.99771017799969)",17,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,58,61.2,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,57.9,61.1,Overall,Overall,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.1,57.1,,,54.5,59.5,Gender,Male,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.2,57.2,,,54.8,59.7,Gender,Male,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62,62,,,60,64.1,Gender,Female,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,59.4,63.5,Gender,Female,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.3,60.3,,,58.6,62,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,58.4,61.7,Race/Ethnicity,"White, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.2,58.2,,,50.9,65.1,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,51.5,65.7,Race/Ethnicity,"Black, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,42.8,42.8,,,29.9,56.8,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.4,46.4,,,34.1,59.3,Race/Ethnicity,Hispanic,"(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,43.2,74.2,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.5,60.5,,,46.5,73,Race/Ethnicity,"Other, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,35.5,68.9,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,IN,Indiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,34.6,69.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.766910452000445, -86.14996019399968)",18,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,,,60.9,63.7,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,60.1,62.8,Overall,Overall,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.6,61.6,,,59.5,63.7,Gender,Male,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,58.8,62.9,Gender,Male,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,61.2,64.8,Gender,Female,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.1,62.1,,,60.3,63.9,Gender,Female,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.2,64.2,,,62.7,65.6,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,61.5,64.3,Race/Ethnicity,"White, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.8,57.8,,,50.4,64.8,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,51.5,65.4,Race/Ethnicity,"Black, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.8,37.8,,,30.3,45.9,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,40.2,40.2,,,32.5,48.4,Race/Ethnicity,Hispanic,"(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,45.4,66.4,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.1,55.1,,,44.7,65.1,Race/Ethnicity,"Other, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.7,55.7,,,45.1,65.8,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,KS,Kansas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55,55,,,44.4,65.3,Race/Ethnicity,"Multiracial, non-Hispanic","(38.34774030000045, -98.20078122699965)",20,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.9,64.9,,,62.9,66.8,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,61.9,65.8,Overall,Overall,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,59.2,65.6,Gender,Male,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,58.6,64.8,Gender,Male,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,64.8,69.4,Gender,Female,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,63.7,68.4,Gender,Female,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.2,65.2,,,63.2,67.2,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.1,64.1,,,62.1,66.1,Race/Ethnicity,"White, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,51.9,71.3,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,52.3,70.5,Race/Ethnicity,"Black, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,40.5,77.7,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,44.5,76.5,Race/Ethnicity,"Other, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,39.9,39.9,,,24.1,58,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,KY,Kentucky,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,42.9,42.9,,,32.1,54.5,Race/Ethnicity,"Multiracial, non-Hispanic","(37.645970271000465, -84.77497104799966)",21,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,59.4,63.3,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58.8,62.7,Overall,Overall,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.2,58.2,,,55,61.4,Gender,Male,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,54.9,61,Gender,Male,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,61.7,66.6,Gender,Female,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.2,63.2,,,60.8,65.6,Gender,Female,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,59.7,64.4,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,58.3,62.9,Race/Ethnicity,"White, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.4,60.4,,,56.4,64.3,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,57.1,64.8,Race/Ethnicity,"Black, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,41.3,41.3,,,26.2,58.2,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.8,43.8,,,31.2,57.2,Race/Ethnicity,Hispanic,"(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,47.7,74.6,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.6,58.6,,,45.5,70.5,Race/Ethnicity,"Other, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,LA,Louisiana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(31.31266064400046, -92.44568007099969)",22,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.6,72.6,,,71,74.2,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.5,72.5,,,70.9,74,Overall,Overall,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.3,72.3,,,69.9,74.6,Gender,Male,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.2,72.2,,,69.8,74.6,Gender,Male,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73,73,,,70.8,75,Gender,Female,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.7,72.7,,,70.6,74.7,Gender,Female,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.6,74.6,,,73,76.2,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,74.3,74.3,,,72.7,75.9,Race/Ethnicity,"White, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,53.2,70.7,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,52.5,69.4,Race/Ethnicity,"Black, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,51.2,68.3,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,54.2,70.6,Race/Ethnicity,Hispanic,"(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.1,62.1,,,50.9,72.2,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,53.7,73,Race/Ethnicity,"Other, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.8,74.8,,,61.5,84.6,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MA,Massachusetts,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,73.9,73.9,,,61.2,83.6,Race/Ethnicity,"Multiracial, non-Hispanic","(42.27687047000046, -72.08269067499964)",25,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.6,68.6,,,66.7,70.5,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,66.8,70.3,Overall,Overall,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.3,67.3,,,64.1,70.4,Gender,Male,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.6,67.6,,,64.7,70.3,Gender,Male,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,67.4,72.1,Gender,Female,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.5,69.5,,,67.2,71.7,Gender,Female,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.4,69.4,,,67.3,71.5,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.7,68.7,,,66.6,70.7,Race/Ethnicity,"White, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.9,67.9,,,63.3,72.1,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,66.5,73.9,Race/Ethnicity,"Black, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.6,64.6,,,48.5,77.9,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,51.2,75,Race/Ethnicity,Hispanic,"(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,53.5,73.9,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.4,59.4,,,50.4,67.9,Race/Ethnicity,"Other, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.1,73.1,,,58,84.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MD,Maryland,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,55.7,78.5,Race/Ethnicity,"Multiracial, non-Hispanic","(39.29058096400047, -76.60926011099963)",24,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.4,73.4,,,71.8,75,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.6,72.6,,,70.9,74.3,Overall,Overall,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.2,71.2,,,68.5,73.8,Gender,Male,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,67.5,72.9,Gender,Male,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,75.5,75.5,,,73.5,77.4,Gender,Female,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,74.8,74.8,,,72.7,76.8,Gender,Female,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,74.2,74.2,,,72.5,75.8,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,73.4,73.4,,,71.7,75.1,Race/Ethnicity,"White, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.3,54.3,,,39.4,68.4,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.2,52.2,,,38.5,65.5,Race/Ethnicity,"Other, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ME,Maine,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(45.254228894000505, -68.98503133599962)",23,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.8,68.8,,,67.1,70.5,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.4,68.4,,,66.7,70,Overall,Overall,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67,67,,,64.3,69.5,Gender,Male,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,64.4,69.4,Gender,Male,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.6,70.6,,,68.3,72.7,Gender,Female,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.9,69.9,,,67.6,72,Gender,Female,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.6,69.6,,,67.7,71.3,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.1,69.1,,,67.2,70.8,Race/Ethnicity,"White, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,63.8,75.2,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.7,69.7,,,64.1,74.9,Race/Ethnicity,"Black, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.3,66.3,,,50.7,79,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.2,66.2,,,48.8,80.1,Race/Ethnicity,Hispanic,"(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.8,50.8,,,35.5,65.8,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,45.1,68.7,Race/Ethnicity,"Other, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.5,56.5,,,42.1,69.9,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MI,Michigan,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,45.3,69.7,Race/Ethnicity,"Multiracial, non-Hispanic","(44.6613195430005, -84.71439026999968)",26,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.7,68.7,,,67.4,69.9,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.4,68.4,,,67.2,69.6,Overall,Overall,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.4,66.4,,,64.5,68.2,Gender,Male,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,64.5,68.2,Gender,Male,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,69.2,72.5,Gender,Female,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.4,70.4,,,68.8,72,Gender,Female,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.8,69.8,,,68.6,71.1,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.4,69.4,,,68.2,70.6,Race/Ethnicity,"White, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.5,63.5,,,53.8,72.2,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.4,66.4,,,57.8,74.1,Race/Ethnicity,"Black, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.8,51.8,,,40.1,63.3,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,48.8,69.3,Race/Ethnicity,Hispanic,"(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,49.8,49.8,,,38.9,60.6,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.6,50.6,,,41.8,59.3,Race/Ethnicity,"Other, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.7,69.7,,,52.3,82.8,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MN,Minnesota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,55,82.7,Race/Ethnicity,"Multiracial, non-Hispanic","(46.35564873600049, -94.79420050299967)",27,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.8,59.8,,,57.5,62,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.4,59.4,,,57.1,61.6,Overall,Overall,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.6,54.6,,,51.1,58,Gender,Male,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.2,54.2,,,50.7,57.7,Gender,Male,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,61.5,67.3,Gender,Female,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,61,66.7,Gender,Female,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.2,60.2,,,57.8,62.6,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,57,61.8,Race/Ethnicity,"White, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.7,61.7,,,53.6,69.3,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.3,62.3,,,54,69.9,Race/Ethnicity,"Black, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.2,56.2,,,34.9,75.4,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,48.1,48.1,,,33.4,63.1,Race/Ethnicity,"Other, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,47.9,79.5,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MO,Missouri,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.2,61.2,,,47.4,73.4,Race/Ethnicity,"Multiracial, non-Hispanic","(38.635790776000476, -92.56630005299968)",29,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.7,57.7,,,54.9,60.4,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.1,57.1,,,54.4,59.7,Overall,Overall,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.7,56.7,,,52.2,61.1,Gender,Male,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.3,56.3,,,52,60.5,Gender,Male,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,55.1,61.9,Gender,Female,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.9,57.9,,,54.6,61.2,Gender,Female,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,56.1,63,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.2,58.2,,,54.8,61.5,Race/Ethnicity,"White, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.7,54.7,,,49.8,59.4,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.7,55.7,,,51.2,60.1,Race/Ethnicity,"Black, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MS,Mississippi,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(32.745510099000455, -89.53803082499968)",28,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.1,60.1,,,58,62.2,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.2,58.2,,,56,60.3,Overall,Overall,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.5,59.5,,,56.4,62.6,Gender,Male,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.3,57.3,,,54.2,60.4,Gender,Male,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,57.7,63.6,Gender,Female,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.1,62,Gender,Female,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,59,63.5,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.1,59.1,,,56.8,61.3,Race/Ethnicity,"White, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,41.5,77.4,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,44.3,76.3,Race/Ethnicity,Hispanic,"(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,41.8,41.8,,,33.3,50.7,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.8,43.8,,,36.6,51.3,Race/Ethnicity,"Other, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.5,54.5,,,37.6,70.4,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,MT,Montana,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.8,58.8,,,43.9,72.3,Race/Ethnicity,"Multiracial, non-Hispanic","(47.06652897200047, -109.42442064499971)",30,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.5,68.5,,,66.6,70.3,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.3,67.3,,,65.4,69.2,Overall,Overall,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65,65,,,62.1,67.8,Gender,Male,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,60.8,66.8,Gender,Male,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.4,71.4,,,68.9,73.7,Gender,Female,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,67.8,72.6,Gender,Female,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.2,70.2,,,68,72.2,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,66.3,70.8,Race/Ethnicity,"White, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,63.8,72.3,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.5,67.5,,,63.2,71.6,Race/Ethnicity,"Black, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,31.5,31.5,,,21.8,43,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,31.8,31.8,,,21.6,44,Race/Ethnicity,Hispanic,"(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.3,61.3,,,48.7,72.6,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.4,60.4,,,49.1,70.7,Race/Ethnicity,"Other, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NC,North Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.466220975000454, -79.15925046299964)",37,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,57.5,61.9,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,57.1,61.4,Overall,Overall,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.3,58.3,,,55,61.6,Gender,Male,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58,58,,,54.7,61.2,Gender,Male,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.1,61.1,,,58.3,63.9,Gender,Female,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.6,60.6,,,57.8,63.4,Gender,Female,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.6,60.6,,,58.4,62.8,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.9,59.9,,,57.6,62.1,Race/Ethnicity,"White, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.5,51.5,,,37.8,65,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.1,53.1,,,40.2,65.6,Race/Ethnicity,"Other, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,ND,North Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(47.47531977900047, -100.11842104899966)",38,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.4,62.4,,,61,63.7,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.8,61.8,,,60.4,63.1,Overall,Overall,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.2,61.2,,,59.2,63.3,Gender,Male,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58.6,62.8,Gender,Male,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,61.6,65.2,Gender,Female,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.7,62.7,,,60.9,64.6,Gender,Female,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.6,63.6,,,62.2,65,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,61.5,64.3,Race/Ethnicity,"White, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.3,63.3,,,52.1,73.2,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,51.6,71.3,Race/Ethnicity,"Black, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,32.2,32.2,,,24.4,41.1,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,34.1,34.1,,,26.5,42.7,Race/Ethnicity,Hispanic,"(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,46,69.9,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.5,59.5,,,49.7,68.5,Race/Ethnicity,"Other, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.1,59.1,,,40.5,75.3,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NE,Nebraska,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,46.6,70.9,Race/Ethnicity,"Multiracial, non-Hispanic","(41.6410409880005, -99.36572062299967)",31,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71,71,,,68.8,73,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.8,70.8,,,68.7,72.8,Overall,Overall,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.8,70.8,,,67.4,74,Gender,Male,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.5,70.5,,,67.3,73.6,Gender,Male,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.1,71.1,,,68.3,73.8,Gender,Female,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,68.3,73.7,Gender,Female,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.5,71.5,,,69.2,73.6,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.3,71.3,,,69.1,73.3,Race/Ethnicity,"White, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.5,52.5,,,35,69.4,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.4,54.4,,,38.6,69.4,Race/Ethnicity,"Other, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NH,New Hampshire,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.65595011300047, -71.50036091999965)",33,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,60.6,64.4,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,60.8,64.3,Overall,Overall,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,60.6,66,Gender,Male,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.6,63.6,,,61,66.2,Gender,Male,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,59.2,64.3,Gender,Female,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.7,61.7,,,59.3,64.1,Gender,Female,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.4,65.4,,,63.4,67.4,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.6,64.6,,,62.6,66.5,Race/Ethnicity,"White, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61,61,,,55.4,66.4,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,57.2,67.6,Race/Ethnicity,"Black, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.3,54.3,,,47.9,60.6,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.2,57.2,,,51.2,62.9,Race/Ethnicity,Hispanic,"(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,42.5,62.2,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53,53,,,44,61.7,Race/Ethnicity,"Other, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NJ,New Jersey,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.13057004800049, -74.27369128799967)",34,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,57.5,61.6,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.9,58.9,,,56.8,60.9,Overall,Overall,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.5,59.5,,,56.4,62.6,Gender,Male,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.2,59.2,,,56,62.2,Gender,Male,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.6,59.6,,,56.9,62.3,Gender,Female,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,55.9,61.4,Gender,Female,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,61.8,66.7,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.9,62.9,,,60.3,65.5,Race/Ethnicity,"White, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.1,73.1,,,56.6,85,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,76.3,76.3,,,63.2,85.7,Race/Ethnicity,"Black, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53,53,,,49,56.9,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.5,52.5,,,48.6,56.5,Race/Ethnicity,Hispanic,"(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.2,53.2,,,45.3,60.8,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.6,54.6,,,47,62,Race/Ethnicity,"Other, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NM,New Mexico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(34.52088095200048, -106.24058098499967)",35,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.5,57.5,,,53.9,61.1,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.3,56.3,,,52.9,59.7,Overall,Overall,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.7,53.7,,,48.1,59.2,Gender,Male,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.6,53.6,,,48.3,58.8,Gender,Male,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.2,61.2,,,56.5,65.7,Gender,Female,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,54.1,62.5,Gender,Female,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,57.7,65.1,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.1,60.1,,,56.4,63.7,Race/Ethnicity,"White, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.8,61.8,,,45.6,75.8,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,43.3,72.6,Race/Ethnicity,"Black, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,37.1,37.1,,,26.1,49.7,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,42.6,42.6,,,32.1,53.7,Race/Ethnicity,Hispanic,"(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.9,50.9,,,34.6,67,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.7,46.7,,,36.3,57.5,Race/Ethnicity,"Other, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.8,56.8,,,31.1,79.3,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NV,Nevada,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.1,55.1,,,42.3,67.2,Race/Ethnicity,"Multiracial, non-Hispanic","(39.493240390000494, -117.07184056399967)",32,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.7,65.7,,,63.6,67.8,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.3,65.3,,,63.1,67.4,Overall,Overall,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.1,64.1,,,60.8,67.3,Gender,Male,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,60.6,67,Gender,Male,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,64.3,69.9,Gender,Female,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.3,66.3,,,63.5,69,Gender,Female,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,65.8,70.5,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.4,67.4,,,65,69.7,Race/Ethnicity,"White, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.6,65.6,,,59.3,71.4,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.7,65.7,,,59.7,71.3,Race/Ethnicity,"Black, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.7,59.7,,,52,67,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.3,60.3,,,52.6,67.5,Race/Ethnicity,Hispanic,"(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.6,54.6,,,42.5,66.3,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.2,56.2,,,45.6,66.3,Race/Ethnicity,"Other, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,NY,New York,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(42.82700103200045, -75.54397042699964)",36,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.9,62.9,,,61,64.7,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.4,62.4,,,60.5,64.2,Overall,Overall,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.1,63.1,,,60.2,66,Gender,Male,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,,,59.7,65.4,Gender,Male,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.3,65,Gender,Female,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.2,62.2,,,59.8,64.5,Gender,Female,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,60.7,64.6,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,60,63.9,Race/Ethnicity,"White, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.6,68.6,,,61.5,75,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69.7,69.7,,,63,75.6,Race/Ethnicity,"Black, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,35.3,69,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.1,56.1,,,44,67.5,Race/Ethnicity,"Other, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.8,43.8,,,29.2,59.6,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OH,Ohio,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.3,46.3,,,32.4,60.9,Race/Ethnicity,"Multiracial, non-Hispanic","(40.06021014100048, -82.40426005599966)",39,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,56.5,56.5,,,54.7,58.3,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,54.1,57.6,Overall,Overall,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.8,52.8,,,50,55.6,Gender,Male,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.7,52.7,,,50,55.4,Gender,Male,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.9,59.9,,,57.6,62.2,Gender,Female,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.9,58.9,,,56.6,61.2,Gender,Female,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.9,57.9,,,55.9,59.9,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.7,56.7,,,54.7,58.7,Race/Ethnicity,"White, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.4,58.4,,,50.5,65.8,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.6,57.6,,,49.7,65.1,Race/Ethnicity,"Black, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,34.5,34.5,,,25,45.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,36.2,36.2,,,26.2,47.6,Race/Ethnicity,Hispanic,"(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.1,55.1,,,47.5,62.6,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.6,55.6,,,48.9,62.1,Race/Ethnicity,"Other, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.3,51.3,,,43.4,59.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OK,Oklahoma,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.2,53.2,,,46.1,60.1,Race/Ethnicity,"Multiracial, non-Hispanic","(35.47203135600046, -97.52107021399968)",40,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.4,63.4,,,61,65.7,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.2,62.2,,,59.8,64.6,Overall,Overall,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.3,60.3,,,56.5,63.9,Gender,Male,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,55.7,62.8,Gender,Male,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.3,66.3,,,63.3,69.1,Gender,Female,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62,68.2,Gender,Female,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.8,64.8,,,62.4,67.1,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.5,63.5,,,60.9,65.9,Race/Ethnicity,"White, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.4,52.4,,,37.9,66.6,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.6,53.6,,,39.7,67.1,Race/Ethnicity,Hispanic,"(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,43.5,43.5,,,27.2,61.3,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,45.9,45.9,,,30.8,61.7,Race/Ethnicity,"Other, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.6,63.6,,,52.2,73.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,OR,Oregon,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.1,60.1,,,49.7,69.6,Race/Ethnicity,"Multiracial, non-Hispanic","(44.56744942400047, -120.15503132599969)",41,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,62.8,66.2,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,62.3,65.7,Overall,Overall,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,60.4,65.6,Gender,Male,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.8,62.8,,,60.1,65.4,Gender,Male,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,,,63.6,68,Gender,Female,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,,,62.9,67.4,Gender,Female,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.7,65.7,,,63.9,67.4,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,63.2,66.8,Race/Ethnicity,"White, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,55.7,68.4,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.2,61.2,,,54.8,67.3,Race/Ethnicity,"Black, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.6,51.6,,,37.2,65.7,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,49,49,,,36.1,62.1,Race/Ethnicity,Hispanic,"(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52.3,52.3,,,36.3,67.8,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,56.1,56.1,,,41.5,69.7,Race/Ethnicity,"Other, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,PA,Pennsylvania,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(40.79373015200048, -77.86070029399963)",42,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.6,51.6,,,49.3,53.9,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.8,50.8,,,48.5,53.2,Overall,Overall,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.1,51.1,,,47.3,54.9,Gender,Male,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.4,50.4,,,46.6,54.3,Gender,Male,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,52,52,,,49.2,54.8,Gender,Female,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51.3,51.3,,,48.6,54.1,Gender,Female,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.5,51.5,,,49.1,53.8,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.6,50.6,,,48.3,53,Race/Ethnicity,Hispanic,"(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,PR,Puerto Rico,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.220833, -66.590149)",72,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.5,71.5,,,69.5,73.5,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.1,71.1,,,69.1,73.1,Overall,Overall,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.9,71.9,,,68.7,74.8,Gender,Male,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.6,71.6,,,68.3,74.6,Gender,Male,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.3,71.3,,,68.7,73.7,Gender,Female,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.7,70.7,,,68.1,73.2,Gender,Female,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,73.5,73.5,,,71.4,75.5,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.9,72.9,,,70.8,74.9,Race/Ethnicity,"White, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.7,66.7,,,51.7,78.9,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.9,66.9,,,53.3,78.1,Race/Ethnicity,"Black, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.7,58.7,,,48.9,67.8,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.7,58.7,,,49,67.7,Race/Ethnicity,Hispanic,"(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.8,62.8,,,48.4,75.3,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.5,60.5,,,46.5,73,Race/Ethnicity,"Other, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,RI,Rhode Island,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(41.70828019300046, -71.52247031399963)",44,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.1,65.1,,,63.5,66.7,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.8,63.8,,,62.1,65.5,Overall,Overall,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.1,65,Gender,Male,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.1,61.1,,,58.6,63.6,Gender,Male,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.3,67.3,,,65.1,69.4,Gender,Female,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.1,66.1,,,63.9,68.3,Gender,Female,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67,67,,,65,68.8,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65,65,,,63,67,Race/Ethnicity,"White, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,58.8,65.6,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62,62,,,58.5,65.4,Race/Ethnicity,"Black, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.1,51.1,,,36.3,65.8,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.6,54.6,,,41.2,67.4,Race/Ethnicity,Hispanic,"(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50.9,50.9,,,37.9,63.7,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,50.1,50.1,,,37.9,62.4,Race/Ethnicity,"Other, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,48.9,48.9,,,32.3,65.8,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,SC,South Carolina,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.3,52.3,,,37.8,66.5,Race/Ethnicity,"Multiracial, non-Hispanic","(33.998821303000454, -81.04537120699968)",45,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.5,64.5,,,61.6,67.2,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.3,64.3,,,61.5,67,Overall,Overall,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.9,59.9,,,55.4,64.2,Gender,Male,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60,60,,,55.9,64,Gender,Male,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69,69,,,65.5,72.4,Gender,Female,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,69,69,,,65.4,72.3,Gender,Female,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,62.4,68.1,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.1,65.1,,,62.2,67.9,Race/Ethnicity,"White, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.9,60.9,,,49.2,71.4,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.4,60.4,,,48.7,71,Race/Ethnicity,"Other, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,SD,South Dakota,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.353130053000484, -100.3735306369997)",46,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.2,62.2,,,59.7,64.7,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,58.8,63.8,Overall,Overall,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,61.4,61.4,,,57.3,65.3,Gender,Male,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,56.7,64.8,Gender,Male,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63,63,,,59.8,66,Gender,Female,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.7,61.7,,,58.6,64.7,Gender,Female,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62,62,,,59.3,64.6,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.7,60.7,,,58,63.4,Race/Ethnicity,"White, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,54.1,70.3,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.7,63.7,,,56.3,70.5,Race/Ethnicity,"Black, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,TN,Tennessee,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(35.68094058000048, -85.77449091399967)",47,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,58.5,58.5,,,56.4,60.6,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.4,58.4,,,56.3,60.4,Overall,Overall,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,57.6,57.6,,,54.4,60.7,Gender,Male,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,57.7,57.7,,,54.5,60.7,Gender,Male,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59.4,59.4,,,56.5,62.1,Gender,Female,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,59.3,59.3,,,56.5,61.9,Gender,Female,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.3,64.3,,,61.9,66.7,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.4,63.4,,,60.9,65.7,Race/Ethnicity,"White, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.9,70.9,,,63.7,77.2,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.9,71.9,,,65.1,77.9,Race/Ethnicity,"Black, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,40.5,40.5,,,36.2,45,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,43.5,43.5,,,39.5,47.5,Race/Ethnicity,Hispanic,"(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,45.2,45.2,,,31.4,59.8,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,40.8,40.8,,,28.4,54.4,Race/Ethnicity,"Other, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.9,66.9,,,47.9,81.6,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,TX,Texas,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,53.9,79.7,Race/Ethnicity,"Multiracial, non-Hispanic","(31.827240407000488, -99.42677020599967)",48,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64,64,*,50 States + DC: US Median,62.3,65.1,Overall,Overall,,59,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,62.6,62.6,*,50 States + DC: US Median,61.3,64.3,Overall,Overall,,59,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.3,62.3,*,50 States + DC: US Median,60.3,63.4,Gender,Male,,59,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.1,61.1,*,50 States + DC: US Median,59.9,63.2,Gender,Male,,59,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.8,65.8,*,50 States + DC: US Median,63,67.3,Gender,Female,,59,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,US,United States,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.2,65.2,*,50 States + DC: US Median,62.1,66.3,Gender,Female,,59,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66.8,69.8,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68,68,,,66.5,69.4,Overall,Overall,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.4,68.4,,,66.3,70.6,Gender,Male,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.2,68.2,,,66.1,70.3,Gender,Male,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66.2,70.3,Gender,Female,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.8,67.8,,,65.7,69.8,Gender,Female,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.7,70.7,,,69.2,72.2,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70.3,70.3,,,68.8,71.7,Race/Ethnicity,"White, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.8,47.8,,,40.3,55.3,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,47.4,47.4,,,40.4,54.6,Race/Ethnicity,Hispanic,"(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.5,47.5,,,37.1,58.2,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,51,51,,,40.6,61.3,Race/Ethnicity,"Other, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,UT,Utah,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(39.360700171000474, -111.58713063499971)",49,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.9,66.9,,,65.2,68.7,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.6,66.6,,,64.8,68.3,Overall,Overall,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.4,64.4,,,61.6,67.1,Gender,Male,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64,64,,,61.2,66.8,Gender,Male,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.2,69.2,,,67,71.4,Gender,Female,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.8,68.8,,,66.6,71,Gender,Female,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.8,67.8,,,65.8,69.7,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.2,67.2,,,65.2,69.1,Race/Ethnicity,"White, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,64.7,64.7,,,59.8,69.3,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.6,65.6,,,60.8,70,Race/Ethnicity,"Black, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,60.7,60.7,,,47.2,72.8,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.4,63.4,,,51,74.3,Race/Ethnicity,Hispanic,"(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,55.6,77,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.9,63.9,,,52.2,74.2,Race/Ethnicity,"Other, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,65.3,65.3,,,49.1,78.6,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VA,Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,64.2,64.2,,,48.7,77.2,Race/Ethnicity,"Multiracial, non-Hispanic","(37.54268067400045, -78.45789046299967)",51,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Gender,Male,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Gender,Female,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,"(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VI,Virgin Islands,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic","(18.335765, -64.896335)",78,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,66.2,69.9,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,65.1,68.8,Overall,Overall,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68,68,,,65.2,70.7,Gender,Male,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.2,67.2,,,64.3,69.9,Gender,Male,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,65.6,70.5,Gender,Female,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.8,66.8,,,64.3,69.3,Gender,Female,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.2,68.2,,,66.3,70,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67,67,,,65.1,68.9,Race/Ethnicity,"White, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.6,68.6,,,56.8,78.4,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,46.1,76.4,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,63.1,63.1,,,47.7,76.2,Race/Ethnicity,"Other, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,VT,Vermont,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.62538123900049, -72.51764079099962)",50,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,67.2,67.2,,,65.4,68.9,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.4,66.4,,,64.6,68.1,Overall,Overall,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,66.1,66.1,,,63.3,68.7,Gender,Male,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,65.6,65.6,,,62.8,68.2,Gender,Male,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.3,68.3,,,66,70.4,Gender,Female,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,67.1,67.1,,,64.8,69.3,Gender,Female,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,69.3,69.3,,,67.5,71,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,68.3,68.3,,,66.4,70,Race/Ethnicity,"White, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,68.1,68.1,,,54.5,79.2,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,66.7,66.7,,,53.5,77.7,Race/Ethnicity,"Black, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,44,44,,,33.9,54.6,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,46.6,46.6,,,36.4,57.1,Race/Ethnicity,Hispanic,"(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,55.9,55.9,,,47.6,63.8,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.9,55.9,,,48.2,63.4,Race/Ethnicity,"Other, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WA,Washington,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.9,71.9,,,58.7,82.2,Race/Ethnicity,"Multiracial, non-Hispanic","(47.52227862900048, -120.47001078999972)",53,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,71.7,71.7,,,69.6,73.7,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.3,71.3,,,69.2,73.3,Overall,Overall,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,70.5,70.5,,,67.4,73.5,Gender,Male,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,70,70,,,66.9,73,Gender,Male,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72.8,72.8,,,70,75.5,Gender,Female,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,72.4,72.4,,,69.5,75.2,Gender,Female,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,72,72,,,69.9,74.1,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,71.4,71.4,,,69.2,73.4,Race/Ethnicity,"White, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,85.8,85.8,,,72.4,93.3,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,84.6,84.6,,,72.1,92.1,Race/Ethnicity,"Black, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,51.9,51.9,,,35.1,68.3,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,52.7,52.7,,,36.1,68.8,Race/Ethnicity,"Other, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WI,Wisconsin,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(44.39319117400049, -89.81637074199966)",55,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.6,62.6,,,60.6,64.5,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61,61,,,59,62.9,Overall,Overall,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.7,62.7,,,59.7,65.6,Gender,Male,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,60.8,60.8,,,57.9,63.7,Gender,Male,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,62.5,62.5,,,59.9,65,Gender,Female,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.3,61.3,,,58.6,63.9,Gender,Female,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,63.1,63.1,,,61.1,65.1,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,61.5,61.5,,,59.5,63.5,Race/Ethnicity,"White, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.9,54.9,,,41.1,68,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.7,55.7,,,42.5,68.2,Race/Ethnicity,"Black, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,"(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WV,West Virginia,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(38.66551020200046, -80.71264013499967)",54,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.4,54.4,,,52,56.8,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,53.9,53.9,,,51.5,56.2,Overall,Overall,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,OVERALL,OVR
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,50,50,,,46.2,53.7,Gender,Male,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,GENDER,GENM
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,49.6,49.6,,,46.1,53.2,Gender,Male,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,GENDER,GENM
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,59,59,,,56.1,61.8,Gender,Female,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,GENDER,GENF
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,58.3,58.3,,,55.5,61.2,Gender,Female,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,GENDER,GENF
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,54.9,54.9,,,52.4,57.4,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,54.4,54.4,,,52,56.7,Race/Ethnicity,"White, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,WHT
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,BLK
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,47.8,47.8,,,34.3,61.6,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,47,47,,,34.8,59.6,Race/Ethnicity,Hispanic,"(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,HIS
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,53.1,53.1,,,36.5,69.1,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,55.6,55.6,,,41.7,68.7,Race/Ethnicity,"Other, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,OTH
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,CrdPrev,RACE,MRC
2014,2014,WY,Wyoming,BRFSS,Cancer,"Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years",%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic","(43.23554134300048, -108.10983035299967)",56,CAN,CAN3_0,AgeAdjPrev,RACE,MRC
